癌症类别
肺癌
乳腺癌
结直肠癌
前列腺癌
甲状腺癌
宫颈癌
胃癌
肝癌
胆囊癌
卵巢癌
食管癌
胰腺癌
膀胱癌
淋巴瘤
子宫内膜癌
肾癌
罕见肿瘤
多发性骨髓瘤
白血病
乳腺癌首页
初识乳腺癌
诊断筛查
乳腺癌特药
乳腺癌治疗
寻医问诊
乳腺癌护理
乳腺癌复发转移
预防乳腺癌
嘉和生物一类创新药汝佳宁?(盐酸来罗西利片)上市申请获国家药品监督管理局批准
优赫得(德曲妥珠单抗)在华获批首个适应症用于治疗HER2阳性晚期乳腺癌患者
全球首款口服SERD艾拉司群获批
再鼎医药新型HER2单抗马吉妥昔单抗(Margetuximab)国内获批上市!
轩竹生物轩悦宁(吡洛西利片)获批乳腺癌单药及联合双适应症;作为国内唯一单药适应症的CDK4/6抑制剂为乳腺癌患者带来新希望
全球首批!潜在重磅ADC获批治疗乳腺癌
乳腺癌分类
治疗方式
药物类别
药物靶点
搜索药物
免疫药物,PD-1,三阴性乳腺癌,乳腺癌,243,190,2287,1662,2123,1450,辅助治疗,新辅助治疗,1434,453,2291,2268
免疫药物,PD-L1,三阴性乳腺癌,乳腺癌,1151,54,1398,1961,2287,1662,1962
靶向药物,HER-2,2287,1662,4588,乳腺癌,HER2阳性乳腺癌,4589,二线治疗,4587,2746,2297,5336,2291,4386,4680,2268,5680,880,3769,5682,3075,2302,一线治疗
靶向药物,HER-2,873,353,400,乳腺癌,2268,HER2阳性乳腺癌,4844,2287,1662
靶向药物,HER2,2413,2414,2415,854,乳腺癌,2416,2268,HER2阳性乳腺癌,2287,1662,857,三线治疗
靶向药物,HER2,HER2阳性乳腺癌,868,400,33,144,2178,乳腺癌,4864,新辅助治疗,2268,一线治疗,4703,4865,4574,辅助治疗,2287,1662
靶向药物,PARP,1059,乳腺癌,2287,1662,4885,4886,2981,3415,3859,2123,辅助治疗,2268
靶向药物,VEGF,乳腺癌,4920,1662,52
靶向药物,HER-2,33,1117,1197,乳腺癌,2268,4924,2302,2297,HER2阳性乳腺癌
靶向药物,HER-2,1120,2337,33,乳腺癌,2268,HER2阳性乳腺癌,4345,1219,新辅助治疗,2297,2302,3075,一线治疗,4935
靶向药物,HER1,HER2,1118,2268,4975,乳腺癌,2287,1662,HER2阳性乳腺癌,一线治疗
靶向药物,TROP-2,2287,1885,三阴性乳腺癌,乳腺癌,455,1662,4991,2268,二线治疗,4993,4656,3568,4989,4990,4958,三线治疗
靶向药物,HER-2,3764,2178,HER2阳性乳腺癌,乳腺癌,2268,辅助治疗,4697,二线治疗,2287,1662,880,4816
靶向药物,ESR1,6584,2287,1662,6585,乳腺癌,二线治疗
靶向药物,HDAC,4668,4669,4670,乳腺癌,2268
靶向药物,RET,880,4816,乳腺癌
靶向药物,HER2,4686,4687,HER2阳性乳腺癌,乳腺癌,2287,2291,1662
靶向药物,HER2,4824,4825,4826,2287,1662,乳腺癌,HER2阳性乳腺癌,三线治疗,2268
靶向药物,PIK3CA,6510,乳腺癌,2268,6511
靶向药物,PIK3CA,AKT1,PTEN,6518,2268,乳腺癌,6519,二线治疗,2287,1662,2291
靶向药物,TROP-2,6521,6520,乳腺癌,三阴性乳腺癌,二线治疗,2268,3075,2302,1138,5031,10
靶向药物,TROP-2,乳腺癌,6543,6544,2287,1662,27
靶向药物,CDK4/6,6558,乳腺癌,二线治疗
靶向药物,CDK4/6,6593,2268,乳腺癌
化疗药物,,653,乳腺癌,一线治疗,2287,1662
化疗药物,,2453,乳腺癌
化疗药物,,3222,2343,1255,3223,3224,乳腺癌,2268,3225,895
化疗药物,,乳腺癌,二线治疗,2268,2287,1662
内分泌药物,雌激素,165,2268,乳腺癌,2111,4665,1662,辅助治疗
内分泌药物,CDK4/6,2273,2274,乳腺癌,2268,4926,一线治疗,399,405,1255,1138,2123,辅助治疗,3415,2287,2433,HR阳性乳腺癌,1662,4423,5588
内分泌药物,CDK4/6,405,1280,3446,2268,乳腺癌,HR阳性乳腺癌,3077,4958,一线治疗,2126,2287,1662,4956,4954
内分泌药物,雌激素受体,401,乳腺癌,1255,1138,2268,2353,2287,1662,二线治疗,5619,5589,3461,399,4926
内分泌药物,CDK4/6,3461,405,乳腺癌,2268,3462,3030,17,3478,二线治疗,4933,一线治疗
内分泌药物,CDK4/6,HR阳性乳腺癌,乳腺癌,4665,1662,3445,3447,2287,5146,5147,一线治疗,4958,5202,4682,5148,5201,2268
内分泌药物,芳香化酶,乳腺癌,2268,169,一线治疗,2287,1662,辅助治疗
内分泌药物,mTOR,164,2111,2268,乳腺癌,3625,3626,3627,二线治疗,2355,1248,2287,1662
内分泌药物,芳香化酶,170,2268,乳腺癌,辅助治疗,2287,1662
内分泌药物,芳香化酶,1093,乳腺癌,3077,2268,2287,1662,辅助治疗
内分泌药物,GnRH,乳腺癌,947,2268,4650,2287,1662
内分泌药物,GnRH,4694,947,乳腺癌,2268
文章类型
药物类型
关键词
其他热门专题
其他乳腺癌治疗专题
其他乳腺癌护理专题
其他诊断筛查专题